Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Maxim Group Downgrades Palisade Bio to Hold

Maxim Group Downgrades Palisade Bio to Hold

Maxim Group analyst Naz Rahman downgrades Palisade Bio (NASDAQ:PALI) from Buy to Hold.

August 19, 2022

1 minute read

Maxim Group analyst Naz Rahman downgrades Palisade Bio (NASDAQ:PALI) from Buy to Hold.

What 4 Analyst Ratings Have To Say About PNC Financial Services Gr

December 6, 12:02 PM

Analysts have provided the following ratings for PNC Financial Services Gr (NYSE:PNC) within the last quarter: Bullish Somewhat…

October 27, 2:41 PM

The long-awaited, $44 billion deal between Twitter Inc.

February 1, 6:17 AM

Piper Sandler analyst Frank Schiraldi downgrades WSFS Financial (NASDAQ:WSFS) from Overweight to Neutral and lowers the price target from $53 to $52.

July 1, 7:41 AM

Mizuho analyst Vikram Malhorta maintains Welltower OP (NYSE:WELL) with a Buy and lowers the price target from $96 to $93.